ReviewPharmacoEconomics2018

Ponatinib for Treating Acute Lymphoblastic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Matt Stevenson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.